25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Kuros Biosciences AG
Buy, Hold or Sell?

Let's analyze Kuros together

I guess you are interested in Kuros Biosciences AG. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Kuros Biosciences AG. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Kuros Biosciences AG

I send you an email if I find something interesting about Kuros Biosciences AG.

1. Quick Overview

1.1. Quick analysis of Kuros (30 sec.)










1.2. What can you expect buying and holding a share of Kuros? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$1.52
Expected worth in 1 year
$0.22
How sure are you?
60.0%

+ What do you gain per year?

Total Gains per Share
$-1.30
Return On Investment
-6.1%

For what price can you sell your share?

Current Price per Share
$21.19
Expected price per share
$17.49 - $24.25
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Kuros (5 min.)




Live pricePrice per Share (EOD)
$21.19
Intrinsic Value Per Share
$-2.28 - $-0.61
Total Value Per Share
$-0.76 - $0.91

2.2. Growth of Kuros (5 min.)




Is Kuros growing?

Current yearPrevious yearGrowGrow %
How rich?$56.7m$68.8m-$12.1m-21.4%

How much money is Kuros making?

Current yearPrevious yearGrowGrow %
Making money-$16m-$17m$1m6.3%
Net Profit Margin-40.9%-81.1%--

How much money comes from the company's main activities?

2.3. Financial Health of Kuros (5 min.)




2.4. Comparing to competitors in the Medical Devices industry (5 min.)




  Industry Rankings (Medical Devices)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Kuros?

Welcome investor! Kuros's management wants to use your money to grow the business. In return you get a share of Kuros.

First you should know what it really means to hold a share of Kuros. And how you can make/lose money.

Speculation

The Price per Share of Kuros is $21.19. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Kuros.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Kuros, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $1.52. Based on the TTM, the Book Value Change Per Share is $-0.33 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.22 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Kuros.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.43-2.0%-0.43-2.0%-0.46-2.2%-0.37-1.7%-0.46-2.2%
Usd Book Value Change Per Share-0.33-1.5%-0.33-1.5%-0.22-1.0%-0.11-0.5%0.140.7%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.33-1.5%-0.33-1.5%-0.22-1.0%-0.11-0.5%0.140.7%
Usd Price Per Share3.85-3.85-1.92-2.14-1.07-
Price to Earnings Ratio-8.98--8.98--4.21--6.13--3.07-
Price-to-Total Gains Ratio-11.82--11.82--8.82--4.96--4.96-
Price to Book Ratio2.53-2.53-1.04-1.17-0.59-
Price-to-Total Gains Ratio-11.82--11.82--8.82--4.96--4.96-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share21.19
Number of shares47
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.33-0.11
Usd Total Gains Per Share-0.33-0.11
Gains per Quarter (47 shares)-15.31-4.98
Gains per Year (47 shares)-61.22-19.93
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-61-710-20-30
20-122-1320-40-50
30-184-1930-60-70
40-245-2540-80-90
50-306-3150-100-110
60-367-3760-120-130
70-429-4370-140-150
80-490-4980-159-170
90-551-5590-179-190
100-612-6200-199-210

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.010.00.00.0%0.020.00.00.0%
Book Value Change Per Share0.01.00.00.0%0.03.00.00.0%2.03.00.040.0%6.04.00.060.0%9.011.00.045.0%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.010.00.0%0.00.020.00.0%
Total Gains per Share0.01.00.00.0%0.03.00.00.0%2.03.00.040.0%6.04.00.060.0%9.011.00.045.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Kuros Biosciences AG compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.326-0.3260%-0.218-33%-0.106-67%0.141-331%
Book Value Per Share--1.5201.5200%1.846-18%1.957-22%1.414+8%
Current Ratio--2.0622.0620%2.494-17%4.526-54%3.771-45%
Debt To Asset Ratio--0.2530.2530%0.170+49%0.159+59%0.446-43%
Debt To Equity Ratio--0.3380.3380%0.205+65%0.195+74%0.529-36%
Dividend Per Share----0%-0%-0%-0%
Eps---0.429-0.4290%-0.456+6%-0.366-15%-0.457+7%
Free Cash Flow Per Share---0.287-0.2870%-0.242-16%-0.270-6%-0.325+14%
Free Cash Flow To Equity Per Share---0.292-0.2920%-0.141-52%-0.024-92%-0.133-55%
Gross Profit Margin--2.2482.2480%1.554+45%1.556+45%1.278+76%
Intrinsic Value_10Y_max---0.607--------
Intrinsic Value_10Y_min---2.284--------
Intrinsic Value_1Y_max---0.199--------
Intrinsic Value_1Y_min---0.304--------
Intrinsic Value_3Y_max---0.494--------
Intrinsic Value_3Y_min---0.854--------
Intrinsic Value_5Y_max---0.660--------
Intrinsic Value_5Y_min---1.335--------
Market Cap790433618.000+82%143632121.100143632121.1000%71620224.000+101%79979647.020+80%39989823.510+259%
Net Profit Margin---0.409-0.4090%-0.811+98%-1.802+341%-10.789+2538%
Operating Margin---0.265-0.2650%-0.649+145%-1.731+552%-9.163+3354%
Operating Ratio--1.2651.2650%1.748-28%2.797-55%11.090-89%
Pb Ratio13.938+82%2.5332.5330%1.040+144%1.173+116%0.587+332%
Pe Ratio-49.397-450%-8.976-8.9760%-4.210-53%-6.135-32%-3.067-66%
Price Per Share21.190+82%3.8513.8510%1.920+101%2.144+80%1.072+259%
Price To Free Cash Flow Ratio-73.945-450%-13.437-13.4370%-7.930-41%-8.698-35%-4.349-68%
Price To Total Gains Ratio-65.067-450%-11.824-11.8240%-8.825-25%-4.963-58%-4.963-58%
Quick Ratio--1.6551.6550%2.199-25%4.165-60%3.489-53%
Return On Assets---0.211-0.2110%-0.205-3%-0.161-24%-0.173-18%
Return On Equity---0.282-0.2820%-0.247-12%-0.194-31%0.884-132%
Total Gains Per Share---0.326-0.3260%-0.218-33%-0.106-67%0.141-331%
Usd Book Value--56712000.00056712000.0000%68860000.000-18%73000800.000-22%52739800.000+8%
Usd Book Value Change Per Share---0.326-0.3260%-0.218-33%-0.106-67%0.141-331%
Usd Book Value Per Share--1.5201.5200%1.846-18%1.957-22%1.414+8%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.429-0.4290%-0.456+6%-0.366-15%-0.457+7%
Usd Free Cash Flow---10689469.000-10689469.0000%-9031843.600-16%-10064886.940-6%-12141581.490+14%
Usd Free Cash Flow Per Share---0.287-0.2870%-0.242-16%-0.270-6%-0.325+14%
Usd Free Cash Flow To Equity Per Share---0.292-0.2920%-0.141-52%-0.024-92%-0.133-55%
Usd Market Cap790433618.000+82%143632121.100143632121.1000%71620224.000+101%79979647.020+80%39989823.510+259%
Usd Price Per Share21.190+82%3.8513.8510%1.920+101%2.144+80%1.072+259%
Usd Profit---16001563.900-16001563.9000%-17013391.500+6%-13670163.900-15%-15661762.350-2%
Usd Revenue--39125554.80039125554.8000%20966280.200+87%16777920.100+133%9515609.100+311%
Usd Total Gains Per Share---0.326-0.3260%-0.218-33%-0.106-67%0.141-331%
 EOD+5 -3MRQTTM+0 -0YOY+13 -215Y+10 -2410Y+20 -14

3.3 Fundamental Score

Let's check the fundamental score of Kuros Biosciences AG based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-49.397
Price to Book Ratio (EOD)Between0-113.938
Net Profit Margin (MRQ)Greater than0-0.409
Operating Margin (MRQ)Greater than0-0.265
Quick Ratio (MRQ)Greater than11.655
Current Ratio (MRQ)Greater than12.062
Debt to Asset Ratio (MRQ)Less than10.253
Debt to Equity Ratio (MRQ)Less than10.338
Return on Equity (MRQ)Greater than0.15-0.282
Return on Assets (MRQ)Greater than0.05-0.211
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of Kuros Biosciences AG based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5052.087
Ma 20Greater thanMa 5021.938
Ma 50Greater thanMa 10018.568
Ma 100Greater thanMa 20015.254
OpenGreater thanClose21.190
Total4/5 (80.0%)

4. In-depth Analysis

4.1 About Kuros Biosciences AG

Kuros Biosciences AG, a biopharmaceutical company, engages in the commercialization and development for tissue repair and bone regeneration in the United States, the European Union, and internationally. It operates through three segments: Medical Devices, Pharmaceuticals, and Legacy Portfolio. The company offers MagnetOs Granules, an original advanced bone graft based on the submicron needle-shaped NeedleGrip surface technology; MagnetOs Putty, a mold use to fill bony voids for a predictable fusion; MagnetOs Easypack Putty, a ready-to-use mold to be implanted in any intervertebral disc space or posterolateral spine level; and Magnetos Flex Matrix, an open matrix bone graft. Its Fibrin-PTH pipeline products comprise KUR-111 and KUR-113 that are in Phase 2b clinical trials for trauma indications; KUR-113 that is in Phase 2a clinical trial for spinal indications. The company was incorporated in 2016 and is headquartered in Schlieren, Switzerland.

Fundamental data was last updated by Penke on 2024-09-21 12:39:04.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Kuros earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Kuros to the Medical Devices industry mean.
  • A Net Profit Margin of -40.9% means that $-0.41 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Kuros Biosciences AG:

  • The MRQ is -40.9%. The company is making a huge loss. -2
  • The TTM is -40.9%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-40.9%TTM-40.9%0.0%
TTM-40.9%YOY-81.1%+40.2%
TTM-40.9%5Y-180.2%+139.3%
5Y-180.2%10Y-1,078.9%+898.7%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-40.9%-12.3%-28.6%
TTM-40.9%-16.1%-24.8%
YOY-81.1%-15.6%-65.5%
5Y-180.2%-18.0%-162.2%
10Y-1,078.9%-24.0%-1,054.9%
4.3.1.2. Return on Assets

Shows how efficient Kuros is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Kuros to the Medical Devices industry mean.
  • -21.1% Return on Assets means that Kuros generated $-0.21 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Kuros Biosciences AG:

  • The MRQ is -21.1%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -21.1%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-21.1%TTM-21.1%0.0%
TTM-21.1%YOY-20.5%-0.6%
TTM-21.1%5Y-16.1%-5.0%
5Y-16.1%10Y-17.3%+1.3%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-21.1%-3.3%-17.8%
TTM-21.1%-3.8%-17.3%
YOY-20.5%-3.9%-16.6%
5Y-16.1%-3.3%-12.8%
10Y-17.3%-4.2%-13.1%
4.3.1.3. Return on Equity

Shows how efficient Kuros is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Kuros to the Medical Devices industry mean.
  • -28.2% Return on Equity means Kuros generated $-0.28 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Kuros Biosciences AG:

  • The MRQ is -28.2%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -28.2%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-28.2%TTM-28.2%0.0%
TTM-28.2%YOY-24.7%-3.5%
TTM-28.2%5Y-19.4%-8.8%
5Y-19.4%10Y88.4%-107.8%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-28.2%-3.8%-24.4%
TTM-28.2%-4.3%-23.9%
YOY-24.7%-4.4%-20.3%
5Y-19.4%-4.8%-14.6%
10Y88.4%-6.1%+94.5%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Kuros Biosciences AG.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Kuros is operating .

  • Measures how much profit Kuros makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Kuros to the Medical Devices industry mean.
  • An Operating Margin of -26.5% means the company generated $-0.27  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Kuros Biosciences AG:

  • The MRQ is -26.5%. The company is operating very inefficient. -2
  • The TTM is -26.5%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-26.5%TTM-26.5%0.0%
TTM-26.5%YOY-64.9%+38.4%
TTM-26.5%5Y-173.1%+146.5%
5Y-173.1%10Y-916.3%+743.2%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-26.5%-20.8%-5.7%
TTM-26.5%-24.1%-2.4%
YOY-64.9%-14.2%-50.7%
5Y-173.1%-18.3%-154.8%
10Y-916.3%-22.8%-893.5%
4.3.2.2. Operating Ratio

Measures how efficient Kuros is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Devices industry mean).
  • An Operation Ratio of 1.27 means that the operating costs are $1.27 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Kuros Biosciences AG:

  • The MRQ is 1.265. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.265. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.265TTM1.2650.000
TTM1.265YOY1.748-0.482
TTM1.2655Y2.797-1.532
5Y2.79710Y11.090-8.292
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2651.371-0.106
TTM1.2651.376-0.111
YOY1.7481.396+0.352
5Y2.7971.406+1.391
10Y11.0901.377+9.713
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Kuros Biosciences AG.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Kuros is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Devices industry mean).
  • A Current Ratio of 2.06 means the company has $2.06 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Kuros Biosciences AG:

  • The MRQ is 2.062. The company is able to pay all its short-term debts. +1
  • The TTM is 2.062. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.062TTM2.0620.000
TTM2.062YOY2.494-0.432
TTM2.0625Y4.526-2.464
5Y4.52610Y3.771+0.755
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ2.0622.573-0.511
TTM2.0622.650-0.588
YOY2.4943.009-0.515
5Y4.5263.424+1.102
10Y3.7713.502+0.269
4.4.3.2. Quick Ratio

Measures if Kuros is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Kuros to the Medical Devices industry mean.
  • A Quick Ratio of 1.66 means the company can pay off $1.66 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Kuros Biosciences AG:

  • The MRQ is 1.655. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 1.655. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ1.655TTM1.6550.000
TTM1.655YOY2.199-0.544
TTM1.6555Y4.165-2.510
5Y4.16510Y3.489+0.676
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.6551.538+0.117
TTM1.6551.570+0.085
YOY2.1991.855+0.344
5Y4.1652.331+1.834
10Y3.4892.573+0.916
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Kuros Biosciences AG.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Kuros assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Kuros to Medical Devices industry mean.
  • A Debt to Asset Ratio of 0.25 means that Kuros assets are financed with 25.3% credit (debt) and the remaining percentage (100% - 25.3%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Kuros Biosciences AG:

  • The MRQ is 0.253. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.253. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.253TTM0.2530.000
TTM0.253YOY0.170+0.083
TTM0.2535Y0.159+0.093
5Y0.15910Y0.446-0.287
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2530.398-0.145
TTM0.2530.402-0.149
YOY0.1700.356-0.186
5Y0.1590.441-0.282
10Y0.4460.463-0.017
4.5.4.2. Debt to Equity Ratio

Measures if Kuros is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Kuros to the Medical Devices industry mean.
  • A Debt to Equity ratio of 33.8% means that company has $0.34 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Kuros Biosciences AG:

  • The MRQ is 0.338. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.338. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.338TTM0.3380.000
TTM0.338YOY0.205+0.134
TTM0.3385Y0.195+0.144
5Y0.19510Y0.529-0.334
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3380.563-0.225
TTM0.3380.568-0.230
YOY0.2050.529-0.324
5Y0.1950.633-0.438
10Y0.5290.693-0.164
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Kuros generates.

  • Above 15 is considered overpriced but always compare Kuros to the Medical Devices industry mean.
  • A PE ratio of -8.98 means the investor is paying $-8.98 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Kuros Biosciences AG:

  • The EOD is -49.397. Based on the earnings, the company is expensive. -2
  • The MRQ is -8.976. Based on the earnings, the company is expensive. -2
  • The TTM is -8.976. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-49.397MRQ-8.976-40.421
MRQ-8.976TTM-8.9760.000
TTM-8.976YOY-4.210-4.766
TTM-8.9765Y-6.135-2.841
5Y-6.13510Y-3.067-3.067
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-49.397-1.020-48.377
MRQ-8.976-1.291-7.685
TTM-8.976-2.208-6.768
YOY-4.210-2.441-1.769
5Y-6.135-2.466-3.669
10Y-3.067-2.060-1.007
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Kuros Biosciences AG:

  • The EOD is -73.945. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -13.437. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -13.437. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-73.945MRQ-13.437-60.508
MRQ-13.437TTM-13.4370.000
TTM-13.437YOY-7.930-5.507
TTM-13.4375Y-8.698-4.739
5Y-8.69810Y-4.349-4.349
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-73.945-1.416-72.529
MRQ-13.437-1.746-11.691
TTM-13.437-1.847-11.590
YOY-7.930-5.761-2.169
5Y-8.698-4.365-4.333
10Y-4.349-5.000+0.651
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Kuros is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Devices industry mean).
  • A PB ratio of 2.53 means the investor is paying $2.53 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Kuros Biosciences AG:

  • The EOD is 13.938. Based on the equity, the company is expensive. -2
  • The MRQ is 2.533. Based on the equity, the company is underpriced. +1
  • The TTM is 2.533. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD13.938MRQ2.533+11.405
MRQ2.533TTM2.5330.000
TTM2.533YOY1.040+1.493
TTM2.5335Y1.173+1.359
5Y1.17310Y0.587+0.587
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD13.9382.207+11.731
MRQ2.5332.059+0.474
TTM2.5332.331+0.202
YOY1.0402.932-1.892
5Y1.1734.082-2.909
10Y0.5874.560-3.973
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2019-12-312020-12-312021-12-312022-12-312023-12-31
Tax Provision  -666-3-669-1,677-2,347719-1,6272,070443
Net Interest Income  -50219-484-434-917-2,049-2,9675,4672,500
Income Tax Expense  -666-3-669-1,677-2,347719-1,6272,070443



6.2. Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets75,906
Total Liabilities19,194
Total Stockholder Equity56,712
 As reported
Total Liabilities 19,194
Total Stockholder Equity+ 56,712
Total Assets = 75,906

Assets

Total Assets75,906
Total Current Assets27,194
Long-term Assets48,712
Total Current Assets
Cash And Cash Equivalents 14,208
Net Receivables 7,617
Inventory 4,856
Other Current Assets 513
Total Current Assets  (as reported)27,194
Total Current Assets  (calculated)27,194
+/-0
Long-term Assets
Property Plant Equipment 2,642
Goodwill 24,469
Intangible Assets 16,508
Long-term Assets  (as reported)48,712
Long-term Assets  (calculated)43,619
+/- 5,093

Liabilities & Shareholders' Equity

Total Current Liabilities13,187
Long-term Liabilities6,007
Total Stockholder Equity56,712
Total Current Liabilities
Short-term Debt 3,953
Accounts payable 1,301
Other Current Liabilities 7,933
Total Current Liabilities  (as reported)13,187
Total Current Liabilities  (calculated)13,187
+/-0
Long-term Liabilities
Capital Lease Obligations 2,143
Long-term Liabilities  (as reported)6,007
Long-term Liabilities  (calculated)2,143
+/- 3,864
Total Stockholder Equity
Common Stock3,678
Retained Earnings -42,151
Accumulated Other Comprehensive Income 21,886
Other Stockholders Equity 73,299
Total Stockholder Equity (as reported)56,712
Total Stockholder Equity (calculated)56,712
+/-0
Other
Capital Stock3,678
Cash and Short Term Investments 14,208
Common Stock Shares Outstanding 36,582
Liabilities and Stockholders Equity 75,906
Net Debt -8,690
Net Invested Capital 56,712
Net Working Capital 14,007
Property Plant and Equipment Gross 3,713
Short Long Term Debt Total 5,518



6.3. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-31
> Total Assets 
88,366
82,394
57,412
123,559
110,755
68,702
54,071
30,813
30,391
40,502
17,631
3,259
43,768
86,081
85,821
87,852
94,364
91,336
82,946
75,906
75,90682,94691,33694,36487,85285,82186,08143,7683,25917,63140,50230,39130,81354,07168,702110,755123,55957,41282,39488,366
   > Total Current Assets 
67,279
63,746
44,496
112,625
99,637
62,661
50,048
30,570
30,237
40,337
17,551
3,179
13,396
17,674
19,833
23,290
33,968
32,892
31,393
27,194
27,19431,39332,89233,96823,29019,83317,67413,3963,17917,55140,33730,23730,57050,04862,66199,637112,62544,49663,74667,279
       Cash And Cash Equivalents 
21,033
11,469
9,149
43,043
40,322
20,969
33,782
24,542
28,585
39,847
16,935
2,093
12,369
16,673
18,334
20,802
28,388
28,623
24,065
14,208
14,20824,06528,62328,38820,80218,33416,67312,3692,09316,93539,84728,58524,54233,78220,96940,32243,0439,14911,46921,033
       Short-term Investments 
0
379
18,000
66,000
41,000
37,000
8,000
4,000
0
0
0
0
0
0
0
0
0
0
0
0
0000000000004,0008,00037,00041,00066,00018,0003790
       Net Receivables 
1,053
845
0
0
0
0
0
0
0
0
0
169
681
351
627
1,075
3,573
2,047
3,618
7,617
7,6173,6182,0473,5731,0756273516811690000000008451,053
       Inventory 
14,124
14,124
14,124
0
0
0
0
0
0
0
0
0
0
220
547
954
1,460
1,757
3,170
4,856
4,8563,1701,7571,460954547220000000000014,12414,12414,124
       Other Current Assets 
31,069
36,929
0
0
0
0
0
0
0
336
496
0
35
430
325
459
547
465
540
513
513540465547459325430350496336000000036,92931,069
   > Long-term Assets 
21,087
18,648
12,916
10,934
11,118
6,041
4,023
243
154
165
80
80
30,372
68,407
65,988
64,562
60,396
58,444
51,553
48,712
48,71251,55358,44460,39664,56265,98868,40730,37280801651542434,0236,04111,11810,93412,91618,64821,087
       Property Plant Equipment 
14,037
13,591
12,575
10,643
8,383
5,993
3,968
137
86
93
0
3
45
630
634
2,782
2,588
2,447
2,323
2,642
2,6422,3232,4472,5882,782634630453093861373,9685,9938,38310,64312,57513,59114,037
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
23,717
34,546
34,241
33,860
33,847
33,390
29,314
24,469
24,46929,31433,39033,84733,86034,24134,54623,717000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
6,595
33,231
31,113
27,920
23,666
22,607
19,412
16,508
16,50819,41222,60723,66627,92031,11333,2316,595000000000000
       Long-term Assets Other 
7,050
404
18,310
66,254
43,500
37,000
8,000
4,045
68
72
0
0
15
68,407
65,988
-64,562
-60,101
-58,444
-51,049
-16,494
-16,494-51,049-58,444-60,101-64,56265,98868,407150072684,0458,00037,00043,50066,25418,3104047,050
> Total Liabilities 
8,191
8,383
11,512
69,125
78,895
60,461
47,476
42,493
20,362
36,272
43,851
2,590
5,446
12,941
9,338
9,997
9,763
14,360
14,086
19,194
19,19414,08614,3609,7639,9979,33812,9415,4462,59043,85136,27220,36242,49347,47660,46178,89569,12511,5128,3838,191
   > Total Current Liabilities 
4,647
5,253
8,551
8,014
14,333
4,859
4,469
39,560
3,490
5,810
43,851
1,696
3,265
4,656
4,040
3,640
3,876
11,288
12,589
13,187
13,18712,58911,2883,8763,6404,0404,6563,2651,69643,8515,8103,49039,5604,4694,85914,3338,0148,5515,2534,647
       Short-term Debt 
0
0
132
0
0
0
0
35,715
0
0
37,592
0
0
0
0
246
278
317
416
3,953
3,953416317278246000037,5920035,715000013200
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
3,695
0
0
0
0
0
0
0
0
000000003,69500000000000
       Accounts payable 
1,331
1,264
3,008
1,159
800
253
541
328
362
1,492
152
315
1,273
1,320
1,611
1,059
936
846
1,302
1,301
1,3011,3028469361,0591,6111,3201,2733151521,4923623285412538001,1593,0081,2641,331
       Other Current Liabilities 
3,316
3,989
5,411
6,855
13,533
4,606
3,928
3,517
3,128
4,318
6,107
1,381
1,992
3,336
2,429
2,335
2,662
10,125
10,871
7,933
7,93310,87110,1252,6622,3352,4293,3361,9921,3816,1074,3183,1283,5173,9284,60613,5336,8555,4113,9893,316
   > Long-term Liabilities 
3,544
3,130
2,961
61,111
64,562
55,602
43,007
2,933
16,872
30,462
0
894
2,181
8,285
5,298
6,357
5,887
3,072
1,497
6,007
6,0071,4973,0725,8876,3575,2988,2852,181894030,46216,8722,93343,00755,60264,56261,1112,9613,1303,544
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
606
2,181
8,285
5,298
4,215
3,825
1,243
0
0
001,2433,8254,2155,2988,2852,18160600000000000
> Total Stockholder Equity
80,175
74,011
45,900
54,434
31,860
8,241
6,595
-11,680
10,029
4,230
-26,220
669
38,322
73,140
76,483
77,855
84,601
76,976
68,860
56,712
56,71268,86076,97684,60177,85576,48373,14038,322669-26,2204,23010,029-11,6806,5958,24131,86054,43445,90074,01180,175
   Common Stock
462
509
517
526
527
527
527
527
2,241
3,053
3,053
3,240
5,084
8,171
15,059
22,470
32,811
3,281
3,656
3,678
3,6783,6563,28132,81122,47015,0598,1715,0843,2403,0533,0532,241527527527527526517509462
   Retained Earnings -42,151-116,253-101,166-93,152-81,904-69,433-57,157-43,338-299,990-305,255-270,867-239,542-230,326-211,543-210,079-185,090-159,264-152,391-117,842-89,364
   Capital Surplus 00000000000000000000
   Treasury Stock00000000000000000000
   Other Stockholders Equity 
169,077
191,344
197,774
213,172
216,423
217,793
217,611
218,119
247,330
272,044
275,982
297,419
76,576
122,126
130,857
117,230
123,924
154,152
160,559
73,299
73,299160,559154,152123,924117,230130,857122,12676,576297,419275,982272,044247,330218,119217,611217,793216,423213,172197,774191,344169,077



6.4. Balance Sheets

Currency in USD. All numbers in thousands.




6.5. Cash Flows

Currency in CHF. All numbers in thousands.




6.6. Income Statements

Currency in CHF. All numbers in thousands.


6.7. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue33,564
Cost of Revenue-5,780
Gross Profit27,78427,784
 
Operating Income (+$)
Gross Profit27,784
Operating Expense-36,689
Operating Income-8,905-8,905
 
Operating Expense (+$)
Research Development5,599
Selling General Administrative3,557
Selling And Marketing Expenses17,134
Operating Expense36,68926,290
 
Net Interest Income (+$)
Interest Income400
Interest Expense-186
Other Finance Cost-1,931
Net Interest Income2,145
 
Pretax Income (+$)
Operating Income-8,905
Net Interest Income2,145
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-13,347-4,463
EBIT - interestExpense = -9,091
-13,347
-13,541
Interest Expense186
Earnings Before Interest and Taxes (EBIT)-8,905-13,161
Earnings Before Interest and Taxes (EBITDA)-6,153
 
After tax Income (+$)
Income Before Tax-13,347
Tax Provision-380
Net Income From Continuing Ops-13,727-13,727
Net Income-13,727
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses42,469
Total Other Income/Expenses Net-4,442-2,145
 

Technical Analysis of Kuros
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Kuros. The general trend of Kuros is BULLISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Kuros's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (85.7%) Bearish trend (-85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Kuros Biosciences AG.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 24.25.

The bearish price targets are: 19.31 > 17.49 > 17.49.

Tweet this
Kuros Biosciences AG Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Kuros Biosciences AG. The current mas is .

The long score for the Moving Averages is 13/14.
The longshort score for the Moving Averages is 12/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Kuros Biosciences AG Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Kuros Biosciences AG. The current macd is 0.91570473.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Kuros price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Kuros. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Kuros price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Kuros Biosciences AG Daily Moving Average Convergence/Divergence (MACD) ChartKuros Biosciences AG Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Kuros Biosciences AG. The current adx is 41.64.

The long score for the Directional Movement Index (DMI) is 3/7.
The longshort score for the Directional Movement Index (DMI) is 3/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Kuros shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bullish trend. The ADX is declining, the bullish trend is weakening. Could be a potential reversal to the downside. +2
Kuros Biosciences AG Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Kuros Biosciences AG. The current sar is 24.20.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Kuros Biosciences AG Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Kuros Biosciences AG. The current rsi is 52.09. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending down: The RSI is trending down. -1
Kuros Biosciences AG Daily Relative Strength Index (RSI) ChartKuros Biosciences AG Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Kuros Biosciences AG. The current phase is Oversold in bull market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Kuros price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Kuros Biosciences AG Daily Stochastic Oscillator ChartKuros Biosciences AG Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Kuros Biosciences AG. The current cci is -68.22821212.

Kuros Biosciences AG Daily Commodity Channel Index (CCI) ChartKuros Biosciences AG Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Kuros Biosciences AG. The current cmo is -10.0187953.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Kuros Biosciences AG Daily Chande Momentum Oscillator (CMO) ChartKuros Biosciences AG Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Kuros Biosciences AG. The current willr is -100.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Kuros Biosciences AG Daily Williams %R ChartKuros Biosciences AG Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Kuros Biosciences AG.

Kuros Biosciences AG Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Kuros Biosciences AG. The current atr is 0.70632638.

Kuros Biosciences AG Daily Average True Range (ATR) ChartKuros Biosciences AG Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Kuros Biosciences AG. The current obv is 102,909.

Kuros Biosciences AG Daily On-Balance Volume (OBV) ChartKuros Biosciences AG Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Kuros Biosciences AG. The current mfi is 44.07.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Kuros Biosciences AG Daily Money Flow Index (MFI) ChartKuros Biosciences AG Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Kuros Biosciences AG.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-05-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-05-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-21ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-05-23STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-05-24STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-05-28STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-05-30STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-05-31BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-06-07STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-06-10ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-06-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-06-12ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-06-13RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-06-17STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-06-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-06-25RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-06-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-06-28STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-02SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-07-05CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-07-09MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-07-11CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-07-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-19STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-22STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-07-31STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-08-02STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-08-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-08-06CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-08-08MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-08-09MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-08-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-08-14RSI SHORT ENTRY LONG CLOSE70 crossover to downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-08-15STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-08-16CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-20STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-21RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-23MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-08-27STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-28RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-03CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-10STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-12STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-16RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-18SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-09-19SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-20RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-23WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-09-24STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-25MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-10-03SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).

6.3. Candlestick Patterns

Kuros Biosciences AG Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Kuros Biosciences AG based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5052.087
Ma 20Greater thanMa 5021.938
Ma 50Greater thanMa 10018.568
Ma 100Greater thanMa 20015.254
OpenGreater thanClose21.190
Total4/5 (80.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Kuros with someone you think should read this too:
  • Are you bullish or bearish on Kuros? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Kuros? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Kuros Biosciences AG

I send you an email if I find something interesting about Kuros Biosciences AG.


Comments

How you think about this?

Leave a comment

Stay informed about Kuros Biosciences AG.

Receive notifications about Kuros Biosciences AG in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.